| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |